Dupilumab with topical corticosteroids results in rapid and sustained improvement in adults with moderate-to-severe atopic dermatitis across all anatomic regions over 52 weeks

Dupilumab with topical corticosteroids results in rapid and sustained improvement in adults with moderate-to-severe atopic dermatitis across all anatomic regions over 52 weeks Meeting Abstract

publication date

February 1, 2021

webpage

Web of Science

published in

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT Journal

start page

66

end page

66

volume

19